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Background
There is paucity of data regarding disease patterns and
outcome in children with juvenile dermatomyositis from
the Indian subcontinent.
Aim
Retrospective assessment of disease characteristics, com-
plications/ associations, treatment modalities used and
outcome in an inceptional cohort of 20 children with
juvenile dermatomyositis at a tertiary care centre in wes-
tern India.
Materials and methods
Chart review of 20 patients with juvenile dermatomyosi-
tis receiving treatment at a tertiary hospital in Mumbai
from 1997 to 2010.
Results
20 patients (male-12, female-8) were diagnosed as hav-
ing definite or probable juvenile dermatomyositis based
on the Bohan and Peter criteria.. The mean age at diag-
nosis was 7.02 years(range 3 to 15.25 years) and the
mean duration of disease prior to diagnosis was 7.5
months (range 3 weeks-2 years).The most frequent
symptoms at presentation were typical skin rash(100%),
proximal muscle weakness(20/20-100%), fatigue(16/20-
80%), fever(13/20-65%) and arthralgia(11/20-55%).Dys-
phagia was seen in 5/20(25%), cutaneous ulcers in 4/20
(20%), calcinosis in 3/20(15%), lipodystrophy in 2/20
(10%) and pyogenic infections in 2/20 (10%). Hirsutism
was seen in 3/20(15%) and vitiligo in 1/20(5%). One of
the patients had associated insulin dependent diabetes
mellitus and chronic hepatitis. None of the patients in
the cohort presented with or developed cardiomyopathy.
All patients presented with at least one of the four
serum muscle enzyme levels elevated. Interestingly, a
normal range of creatine kinase (CK.) was seen in 11/20
(55%) of the patients. Electromyography was done in 4
patients and muscle biopsy done to confirm the diagno-
sis in one patient. Magnetic resonance imaging of the
thigh muscles was used to as an aid to diagnosis in 10/
20 patients and was abnormal in all
Pulse steroids were used to induce remission in 10
patients and as a rescue for relapses in one patient.
IVIG was used as rescue therapy in 2 children with
good results. All patients received oral steroids and
methotrexate as the standard maintanence treatment.
Hydroxychloroquine was added in patients with domi-
nant cutaneous manifestations. 4 children with inade-
quate response, ulcerative disease or hepatotoxicity
received Azathioprine (4/4), cyclosporine (1/4), cyclo-
phosphamide(1/4) as additional therapy. One child with
extensive calcinosis is being treated with monthly IVIG,
diltiazem and colchicine. The total follow-up period was
62.24 patient-years (range- 0.58 to 12.17 years). A
monocyclic course was seen in 15/20(75%), relapsing
course in 3/20 (15%) and a chronic progressive course
in 2/20(10%).No mortality has been reported till date.
Conclusions
There was a considerable delay at the primary care level
for the diagnosis of juvenile dermatomyositis. A normal
CPK, probably linked to this delay, often led the primary
care pediatricians away from the diagnosis. Calcinosis,
decreasingly reported in Western series is still seen here
and may probably be linked to this delay.MRI has pro-
ven to be a useful tool in the diagnosis and has largely
eliminated the need for a muscle biopsy.
Notwithstanding the delay in diagnosis, absent mortal-
ity, absence of cardio-pulmonary complications and a
monocyclic course in 75% of our patients are at variance
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